share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Nov 21 05:10

Gainers

  • Quantum-Si (NASDAQ:QSI) stock rose 144.9% to $1.55 during Wednesday's pre-market session. The company's market cap stands at $221.2 million.
  • Forte Biosciences (NASDAQ:FBRX) shares moved upwards by 76.53% to $10.46. The company's market cap stands at $15.2 million. The company's, Q3 earnings came out 4 days ago.
  • Silexion Therapeutics (NASDAQ:SLXN) stock rose 72.36% to $0.39. The company's market cap stands at $5.6 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved upwards by 57.59% to $0.26. The market value of their outstanding shares is at $47.9 million.
  • Exicure (NASDAQ:XCUR) shares rose 21.13% to $7.05. The company's market cap stands at $15.3 million. As per the press release, Q3 earnings came out 4 days ago.
  • Tevogen Bio Holdings (NASDAQ:TVGN) shares moved upwards by 19.85% to $1.63. The company's market cap stands at $278.1 million.

Losers

  • Lineage Cell Therapeutics (AMEX:LCTX) shares declined by 19.7% to $0.72 during Wednesday's pre-market session. The company's market cap stands at $136.9 million. As per the press release, Q3 earnings came out 4 days ago.
  • Apollomics (NASDAQ:APLM) shares declined by 17.23% to $0.14. The company's market cap stands at $14.9 million.
  • BrightSpring Health (NASDAQ:BTSGU) stock declined by 16.86% to $56.38.
  • Oncology Institute (NASDAQ:TOI) stock fell 15.56% to $0.15. The market value of their outstanding shares is at $11.4 million.
  • HCW Biologics (NASDAQ:HCWB) shares declined by 15.35% to $0.93. The market value of their outstanding shares is at $35.2 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Eyenovia (NASDAQ:EYEN) shares decreased by 13.93% to $0.1. The market value of their outstanding shares is at $8.8 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment